Tags |
|
|
Links |
|
|
Advice You - Going Public: The Disadvantages
While going public is often touted as a cure-all, surefire way to gain funds for a company, it’s not without its drawbacks. If a company is not in a good posit
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ion to go public, the decision may actually hurt the corporation more than it helps. Even as money flows in from the offering, the costs of setting up and main
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
taining a public corporation are high, and should be taken into consideration before such a drastic step is taken.
Even before a corporation actually goes publ
Even before a corporation actually goes publ
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ic, the costs are high. It’s not uncommon for a company to spend a year beforehand just to get the company in shape and gather necessary documents. Day-to-day
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
activities become difficult as employees struggle to perform preparation work and their normal duties. Since investors want to see a company in excellent fina
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
cial health, every aspect of the corporation must be examined in advance. If a company decides to go public and the offering is unsuccessful, it loses legal an
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
d underwriting expenses in addition to the lost capital.
For many business owners, the biggest costs of going public are personal losses. Privacy vanishes in
For many business owners, the biggest costs of going public are personal losses. Privacy vanishes in
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
a flurry of disclosure requirements, allowing investors, competition, and the general public to peer into previously confidential details of the company. Cost
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
of sales, net income, major customers, and management salaries become available to anyone who cares to look. In some cases, these disclosures could give a subs
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
tantial competitive advantage to competitors, especially those that haven’t yet taken the step of going public.
Those disclosures can also mean huge expenses a
Those disclosures can also mean huge expenses a
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ter a company decides to go public. Quarterly and annual SEC filings are required, and regular tax preparation becomes more complicated than before. Additiona
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
l legal and accounting staff may be necessary to keep up.
When a company decides to go public, decision-making privileges are quick to go. Instead of making i
When a company decides to go public, decision-making privileges are quick to go. Instead of making i
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
nstinctual, unilateral decisions, shareholders must be considered and it may be necessary to consult with the board of directors. The kind of decision-making t
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
hat made the company successful can give way to actions borne out the desire to minimize immediate risk and maximize shareholder revenue. Unhappy shareholders
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
can drive down the company’s value, damaging employee morale, personal wealth, and company reputation.
If insiders of a company fail to hold onto a majority of
If insiders of a company fail to hold onto a majority of
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
the corporation’s shares, the loss of control can be even greater. While this can be mitigated by limiting the number of shares made available, it’s a costly o
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ption to a company that is attempting to raise money. Some corporations going public prefer to offer voting-restricted shares. Such restrictions reduce raised
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
capital in a more subtle way. Investors pay less for shares with fewer privileges, so the total funds raised are lower, even though a large number of shares i
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
s being offered.
Despite the drawbacks, many corporations find that going public is the most effective way to expand a business quickly without the use of trad
Despite the drawbacks, many corporations find that going public is the most effective way to expand a business quickly without the use of trad
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
itional debt financing. For those that have carefully considered the positives and negatives, the transition can be smooth and prosperous for everyone involved
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/44942/adviceyou-Going-Public-The-Disadvantages.html">Going Public: The Disadvantages</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/44942/adviceyou-Going-Public-The-Disadvantages.html]Going Public: The Disadvantages[/url]
Related Articles:
Reaping The Advantages of Newspaper Classified Advertising
Bookmark it:
|